跳至主要内容
临床试验/NCT04937023
NCT04937023Unknown不适用

Assessing the Clinical Efficacy of Ursodeoxycholic Acid (Udca) as a Local Drug Delivery Agent in the Treatment of Intra-bony Defects: A Clinico-radiographic Study

SVS Institute of Dental Sciences1 个研究点 分布在 1 个国家目标入组 26 人开始时间: 2021年6月11日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
26
试验地点
1
主要终点
Evaluation if clinical attachment level

研究概览

简要总结

The aim of this study is to evaluate the efficacy of ursodeoxycholic acid as local drug delivery agent in intra- bony defect to achieve bone regeneration.

详细描述

Experimental: Main treatment group the prepared UDCA gel will be injected using a syringe with blunt cannula into the defect site.

Comparator: In patients allocated to control group, placebo gel will be injected in to the defect site using a syringe with blunt cannula.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
20 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Systemically healthy male and female patients of age>18 years with intrabony defects - two wall or three wall defects and probing pocket depths (PPD) of >3mm will be included

排除标准

  • Medically compromised patients, pregnant women, heavy smokers, and patients who underwent radiotherapy or chemotherapy will be excluded.

研究组 & 干预措施

UDCA gel will be injected using a syringe with blunt cannula into the defect site

Experimental

In the test group, the prepared UDCA gel will be injected using a syringe with blunt cannula into the two or three wall intra-bony defects with probing pocket depth ≥3mm after performing SRP.

干预措施: Ursodeoxycholic acid gel (Drug)

placebo gel will be injected in to the defect site using a syringe with blunt cannula.

Placebo Comparator

In patients allocated to control group, placebo gel will be injected in to the defect site using a syringe with blunt cannula after scaling and root planing.

干预措施: Ursodeoxycholic acid gel (Drug)

结局指标

主要结局

Evaluation if clinical attachment level

时间窗: Baseline to 6 months

Assessment of clinical attachment level (CAL) using UNC-15 probe at baseline and post-operatively at 3 and 6 months.

Evaluation of bone regeneration

时间窗: Baseline to 6 months

Radiovisiography (RVG) will be used to assess bone regeneration achieved post-operatively after 3 months and 6 months.

Evaluation of probing pocket depth

时间窗: Baseline to 6 months

Assessment of probing pocket (PPD) depth using UNC- 15 probe at baseline and postoperatively at 3 and 6 months.

次要结局

  • Evaluation of gingival bleeding(Baseline to 6 months)
  • Evaluation of gingiva(Baseline to 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr R Viswa Chandra

Primary Investigator

SVS Institute of Dental Sciences

研究点 (1)

Loading locations...

相似试验